GLP-1 and muscle loss — 6 alarming facts the research reveals.

GLP-1 and muscle loss is a topic that gets less attention than it deserves. Most conversations about GLP-1 medications focus entirely on the number on the scale, but not all weight loss is created equal.

Some of that lost weight is fat. Some of it is muscle. Understanding the GLP-1 and muscle loss relationship — and what you can do about it — is essential for anyone using these medications for meaningful weight loss. This article follows body composition research from GLP-1 clinical trial sub-studies, alongside general NHS strength training guidance. Contact our 24/7 support team with any questions.

GLP-1 and muscle loss — fact 1: the drug isn’t the direct cause

GLP-1 and muscle loss is often misunderstood as a direct drug side effect. It is not. GLP-1 medications do not attack muscle tissue through their mechanism of action.

The muscle loss associated with GLP-1 treatment happens because of the calorie deficit the medication creates, not because of the drug’s pharmacology. Any significant, sustained calorie deficit — regardless of how it is achieved — puts both fat and muscle tissue at risk unless specific protective steps are taken.

GLP-1 and muscle loss — fact 2: the numbers are significant

Body composition sub-studies from major GLP-1 clinical trials indicate that without intervention, lean mass can account for roughly 25 to 40 percent of total weight lost. This is a substantial proportion — meaning for every 4 pounds lost, potentially 1 to 1.6 pounds could be muscle rather than fat.

This range varies considerably based on individual factors including starting body composition, age, sex, activity level, and — critically — whether protective interventions like resistance training and adequate protein are prioritised during treatment.

GLP-1 and muscle loss — fact 3: not a new problem

The GLP-1 and muscle loss relationship mirrors what researchers have observed with essentially every significant weight loss method. Calorie restriction diets, bariatric surgery, and other weight loss interventions all show similar patterns of lean mass loss alongside fat loss.

This is not a flaw unique to GLP-1 medications — it is a fundamental characteristic of significant weight loss generally. What makes GLP-1 treatment notable is simply the scale and speed of weight loss many people achieve, which brings this pre-existing issue into sharper focus.

GLP-1 and muscle loss — fact 4: age matters enormously

Older adults face a compounded risk in the GLP-1 and muscle loss equation. Age-related muscle loss — sarcopenia — already reduces lean mass naturally from around age 30 onwards, accelerating after 60.

Adding rapid, significant weight loss on top of existing sarcopenia risk can meaningfully affect strength, mobility, and independence in older patients. Clinicians increasingly recommend that older adults on GLP-1 medications prioritise muscle-preserving strategies even more strictly, and some recommend more gradual weight loss targets specifically to protect lean mass.

GLP-1 and muscle loss — fact 5: resistance training changes everything

This is the most actionable fact in the entire GLP-1 and muscle loss conversation. Studies of intentional weight loss consistently show that resistance training — even just 2 to 3 sessions per week — substantially reduces the proportion of lean mass lost compared to weight loss without it.

Resistance training does not need to be complex or gym-based. Bodyweight exercises, resistance bands, or simple free weight routines performed consistently can provide the muscle-preserving stimulus needed. The mechanism is straightforward — resistance exercise signals to the body that muscle tissue is being actively used and needs to be maintained, even during a calorie deficit.

GLP-1 and muscle loss — fact 6: protein intake is equally critical

The second pillar of protecting against GLP-1 and muscle loss is adequate protein intake — typically recommended at 1.2 to 1.6 grams per kilogram of body weight daily for people actively losing weight. This is meaningfully higher than general population recommendations.

This can be genuinely challenging on GLP-1 medications, since appetite suppression often makes hitting protein targets difficult. Prioritising protein-rich foods at each meal — even small ones — and considering protein supplementation when appetite is very low are both practical strategies worth discussing with your prescriber or a dietitian.

For more on protecting muscle during treatment, read our guide on retatrutide and exercise and protein intake on GLP-1 on our blog. Explore our Mounjaro and retatrutide product pages, or read patient reviews.